What's Happening With Moderna Stock?

Moderna stock has rallied by almost 15% over the past month, as the company continues with its phase 3 clinical trials, with late-stage clinical data likely available in the next month or so. Moderna says that it could file for emergency use authorization from the U.S. FDA around November 25...